Tenure-track/Tenure-eligible Investigator

Review begins: January 3, 2022

The Laboratory of Human Carcinogenesis (LHC) at the Center for Cancer Research (CCR) at the National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland is recruiting a tenure-track investigator or preferably a tenure-eligible investigator focused on health disparity of cancer to join the Intramural Research Program’s mission of high impact, high reward science. This position, which is supported with stable financial resources, is the equivalent of Professor /Associate Professor in an academic department. The LHC is looking for a candidate who will complement our current group of four dynamic and collaborative principal investigators (https://ccr.cancer.gov/laboratory-of-human-carcinogenesis#lab-staff-tab-2). Applicants should hold a Ph.D. and/or M.D. degree or equivalent doctoral degree and should have at least ten years of research experience after their terminal degree(s); a substantive record of publications; and, research productivity in molecular and biological epidemiology and health disparity to develop an outstanding independent molecular-based program in health disparity of lung cancer.

About NCI's Center for Cancer Research 
The Center for Cancer Research (CCR) is an intramural research component of the National Cancer Institute (NCI). CCR’s enabling infrastructure facilitates clinical studies at the NIH Clinical Center, the world’s largest dedicated clinical research complex; provides extensive opportunities for collaboration; and allows scientists and clinicians to undertake high-impact laboratory- and clinic-based investigations.  Investigators are supported by a wide array of intellectual and technological and research resources, including animal facilities and dedicated, high quality technology cores in areas such as imaging/microscopy, including cryo-electron microscopy; chemistry/purification, mass spectrometry, flow cytometry, SAXS, genomics/DNA sequencing, transgenics and knock out mice, arrays/molecular profiling, and human genetics/bioinformatics.  For an overview of CCR, please visit http://ccr.cancer.gov/ .

Salary is commensurate with education and experience.  A full benefits package is available, including retirement, health insurance, life insurance, long-term care insurance, annual and sick leave, Thrift Savings Plan (401K equivalent).  Candidates may be U.S. citizens, permanent residents, or possess (or be eligible for) an appropriate work visa.

Interested applicants should submit:

  • A current curriculum vitae and complete bibliography. Please include in your CV a description of your mentoring and outreach activities, especially those involving women and persons from racial/ethnic and other groups that are underrepresented in biomedical research.  
  • A two-page summary of research interests, goals, and future plans

Applications must be submitted to:  https://service.cancer.gov/ccr-careers.  Initial review of applications will begin in early January 2022, but applications will be accepted until the position is filled.   Applications will be treated as confidential.  For more information, contact Lori Holliday, Faculty Recruitment Coordinator at hollidal@mail.nih.gov.

Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization.  NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis.  This position is subject to a background investigation.  

As a condition of employment, all federal employees must be fully vaccinated against COVID-19.  During the onboarding process, if selected, you must provide proof of vaccination.  An official job offer and continued employment is contingent on this requirement.  For more information on this requirement, visit the Safer Federal Workforce page on vaccines. If you need a COVID-19 vaccine, please visit Vaccines.gov

Due to COVID-19, we are currently operating in a maximum telework state. If selected, you may be expected to telework. As employees return to the office, you may be required to report to the location listed on this announcement within 30 calendar days of receiving notice, even if your home/temporary telework site is located outside the local commuting area. At the discretion of the supervisor and NIH policy, you may be eligible for workplace flexibilities, which may include remote work or telework options, and/or flexible work scheduling. These flexibilities may be requested in accordance with NIH Workplace Flexibilities guidance.
                      
The NCI and the CCR are deeply committed to diversity of thought, equity and inclusion and encourages applications from qualified women, under-represented minorities, and individuals with disabilities.  HHS, NIH, and NCI are equal opportunity employers.